Agency Forms Undergoing Paperwork Reduction Act Review, 38599-38600 [E7-13605]

Download as PDF 38599 Federal Register / Vol. 72, No. 134 / Friday, July 13, 2007 / Notices these activities elicit the desired effects or impact. ATSDR is requesting a reinstatement with minor changes for the following customer satisfaction surveys: • ATSDR Web Site User Satisfaction Survey (WSUS) • Toxicological Profiles User Satisfaction Survey (TPUS) • ToxFAQsTM User Satisfaction Survey (TFUS) • Public Health Statements User Satisfaction Survey (PHSUS) • Toxicology Curriculum for Communities Training Manual User Satisfaction Survey (TCCUS) • ToxProfilesTM CD–ROM User Satisfaction Survey (TP–CDUS) The results of this project will ensure that these audiences will continue to find our knowledge products and informational pieces easy to access, clear, informative and useful. Specifically, this project will continue to examine whether current and future informational updates are presented in an appropriate technological format and whether they meet the needs, wants, and preferences of visitors to the ATSDR Web site. The survey questions have been held to the absolute minimum required for the use of the data. This extension request is for a threeyear period. There are no costs to the respondents other than their time. The total estimated annualized burden hours are 166. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Type of respondents Form name ATSDR Web site Visitors ................................ WSUS ............................................................. TPUS .............................................................. TFUS .............................................................. PHSUS ........................................................... TCCUS ........................................................... TP–CDUS ....................................................... Dated: July 9, 2007. Maryam I. Daneshvar, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E7–13597 Filed 7–12–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention 1000 300 300 100 160 140 comments should be received within 30 days of this notice. Proposed Project CDC Model Performance Evaluation Program (MPEP) (0920–0274)— Revision—National Center for Preparedness, Detection, and Control of Infectious Diseases (proposed) (NCPDCID), Centers for Disease Control and Prevention (CDC). Background and Brief Description [30Day–07–0274] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 639–5960 or send an e-mail to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 395–6974. Written Number of responses per respondent CDC is requesting OMB approval of a revision to its data collection, the CDC Model Performance Evaluation Program (MPEP). CDC originally implemented MPEP in 1986 to evaluate the performance of laboratories conducting testing to detect human immunodeficiency virus type 1 (HIV–1) antibody (Ab). CDC is requesting a 3year approval for this data collection. In this program, respondents receive 2 shipments of specimens per year. Respondents test the specimens in their laboratory/testing site and report their results either using a report booklet or on-line. CDC provides the respondent with a report containing the analysis of the laboratory test results reported to CDC. Participation in this program is 1 1 1 1 1 1 Average burden per response (in hours) 5/60 5/60 5/60 5/60 5/60 5/60 voluntary and provides the respondents an opportunity to (1) assure accurate tests are being provided by the laboratory/testing site through external quality assessment; (2) improve testing quality through self-evaluation in a nonregulatory environment; (3) test well characterized samples from a source outside the test kit manufacturer; (4) discover potential testing problems so that procedures can be adjusted to eliminate them; (5) compare of testing results with others at a national and international level; and (6) consult with CDC staff to discuss testing issues. In this request, CDC proposes to make the following revisions to the currently approved data collection: • Addition of a Name and Address change form to report changes for the MPEP manager and coordinator at the respondent laboratory; • Inclusion of additional test kit manufacturers approved by the FDA since previous OMB approval; and • Elimination of reporting HIV–1 RNA Viral Load and CD4+ T-cell determinations. There are no costs to the respondents other than their time to complete the survey. The total estimated annualized burden hours are 257. pwalker on PROD1PC71 with NOTICES TOTAL ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Respondents New Enrollees ........................................................................................................................ Laboratory Change Form ...................................................................................................... VerDate Aug<31>2005 19:05 Jul 12, 2007 Jkt 211001 PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 E:\FR\FM\13JYN1.SGM 100 20 13JYN1 Number of responses per respondent 1 1 Average burden per response (in hours) 3/60 3/60 38600 Federal Register / Vol. 72, No. 134 / Friday, July 13, 2007 / Notices TOTAL ESTIMATED ANNUALIZED BURDEN HOURS—Continued Number of respondents Respondents Laboratory Test Result Form ................................................................................................. Dated: July 9, 2007. Maryam Daneshvar, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E7–13605 Filed 7–12–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Committee on Childhood Lead Poisoning Prevention (ACCLPP), National Center for Environmental Health (NCEH) pwalker on PROD1PC71 with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announce the following meeting of the aforementioned committee: Times and Dates: 8:30 a.m.–5 p.m., September 18, 2007. 8:30 a.m.–12:30 p.m., September 19, 2007. Place: Radisson Plaza Hotel Minneapolis, 35 South 7th Street, Minneapolis, MN 55402, Telephone: (612) 339–4900. Open to the public, limited only by the space available. The meeting room accommodates approximately 75 people. Purpose: The Committee provides advice and guidance to the Secretary; the Assistant Secretary for Health; and the Director, CDC, regarding new scientific knowledge and technological developments and their practical implications for childhood lead poisoning prevention efforts. The Committee also reviews and reports regularly on childhood lead poisoning prevention practices and recommends improvements in national childhood lead poisoning prevention efforts. Matters To Be Discussed: The meeting will include discussion on the potential approaches to strengthen existing strategies to achieve the Healthy People 2010 goal of eliminating Elevated Blood Lead Levels as a Public Health Problem in the United States by 2010, the development of a prevention based research agenda, and the study designs related to adverse effects from Blood Lead Levels (BLLs) < 10 µg/dl; and updates on the school performance and concurrent BLLs. Agenda items are subject to change as priorities dictate. Opportunities will be provided during the meeting for oral comments. Depending on the time available and the number of requests, it may be necessary to limit the time of each presenter. VerDate Aug<31>2005 19:05 Jul 12, 2007 Jkt 211001 Contact Person for More Information: Claudine Johnson, Clerk, Lead Poisoning Prevention Branch, Division of Environmental Emergency Health Services, NCEH, CDC, 4770 Buford Hwy, NE., Mailstop F–40, Atlanta, GA 30341, Telephone (770) 488–3629, Fax (770) 488–3635. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: July 6, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–13596 Filed 7–12–07; 8:45 am] BILLING CODE 4163–18–P Number of responses per respondent 754 Average burden per response (in hours) 2 10/60 evaluation of research grant applications in response to RFA DP07–707, ‘‘Racial and Ethnic Approaches to Community Health Across the United States (REACH US).’’ For Further Information Contact: Thijuanie Lockhart, Program & Management Analyst, CDC, 4770 Buford Highway, NE., Mail Stop K–30, Atlanta, GA 30341, Telephone (404) 488–5303. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: July 9, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–13602 Filed 7–12–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Racial and Ethnic Approaches to Community Health Across the United States (REACH US), Request for Applications (RFA) DP07– 707 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Public Law 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting of the aforementioned Special Emphasis Panel. Times and Dates: 3 p.m.–8 p.m., July 31, 2007 (Closed), 8 a.m.–5 p.m., August 1, 2007 (Closed), 8 a.m.–5 p.m., August 2, 2007 (Closed), 3 p.m.–8 p.m., August 6, 2007 (Closed), 8 a.m.–5 p.m., August 7, 2007 (Closed), 8 a.m.–5 p.m., August 8, 2007 (Closed), 8 a.m.–5 p.m., August 9, 2007 (Closed). Place: Sheraton Gateway Hotel Atlanta Airport, 1900 Sullivan Road, Atlanta, GA 30337, Telephone (800) 454–6835. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Pub. L. 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Statement of Organization, Functions, and Delegations of Authority Part C (Centers for Disease Control and Prevention) of the Statement of Organization, Functions, and Delegations of Authority of the Department of Health and Human Services (45 FR 67772–67776, dated October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as amended most recently at 72 FR 35491–35492, dated June 28, 2007) is amended to reflect the establishment of the Extramural Research Program Office within the National Center for Chronic Disease Prevention and Health Promotion, Coordinating Center for Health Promotion, Centers for Disease Control and Prevention. Section C–B, Organization and Functions, is hereby amended as follows: After the functional statement for the Program Services Branch (CUC13), Office of the Director (CUC1), National Center for Chronic Disease Prevention and Health Promotion (CUC), insert the following: Extramural Research Program Office (CUC18). The Extramural Research Program Office (ERPO) plans, develops, E:\FR\FM\13JYN1.SGM 13JYN1

Agencies

[Federal Register Volume 72, Number 134 (Friday, July 13, 2007)]
[Notices]
[Pages 38599-38600]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-13605]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-07-0274]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail 
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of 
Management and Budget, Washington, DC or by fax to (202) 395-6974. 
Written comments should be received within 30 days of this notice.

Proposed Project

    CDC Model Performance Evaluation Program (MPEP) (0920-0274)--
Revision--National Center for Preparedness, Detection, and Control of 
Infectious Diseases (proposed) (NCPDCID), Centers for Disease Control 
and Prevention (CDC).

Background and Brief Description

    CDC is requesting OMB approval of a revision to its data 
collection, the CDC Model Performance Evaluation Program (MPEP). CDC 
originally implemented MPEP in 1986 to evaluate the performance of 
laboratories conducting testing to detect human immunodeficiency virus 
type 1 (HIV-1) antibody (Ab). CDC is requesting a 3-year approval for 
this data collection.
    In this program, respondents receive 2 shipments of specimens per 
year. Respondents test the specimens in their laboratory/testing site 
and report their results either using a report booklet or on-line. CDC 
provides the respondent with a report containing the analysis of the 
laboratory test results reported to CDC. Participation in this program 
is voluntary and provides the respondents an opportunity to (1) assure 
accurate tests are being provided by the laboratory/testing site 
through external quality assessment; (2) improve testing quality 
through self-evaluation in a non-regulatory environment; (3) test well 
characterized samples from a source outside the test kit manufacturer; 
(4) discover potential testing problems so that procedures can be 
adjusted to eliminate them; (5) compare of testing results with others 
at a national and international level; and (6) consult with CDC staff 
to discuss testing issues.
    In this request, CDC proposes to make the following revisions to 
the currently approved data collection:
     Addition of a Name and Address change form to report 
changes for the MPEP manager and coordinator at the respondent 
laboratory;
     Inclusion of additional test kit manufacturers approved by 
the FDA since previous OMB approval; and
     Elimination of reporting HIV-1 RNA Viral Load and CD4+ T-
cell determinations.
    There are no costs to the respondents other than their time to 
complete the survey. The total estimated annualized burden hours are 
257.

                                     Total Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                   Number of      Average burden
                         Respondents                              Number of      responses per     per response
                                                                 respondents       respondent       (in hours)
----------------------------------------------------------------------------------------------------------------
New Enrollees................................................              100                1             3/60
Laboratory Change Form.......................................               20                1             3/60

[[Page 38600]]

 
Laboratory Test Result Form..................................              754                2            10/60
----------------------------------------------------------------------------------------------------------------


    Dated: July 9, 2007.
Maryam Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
 [FR Doc. E7-13605 Filed 7-12-07; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.